ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC

Englisch Name:: ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC

Synonyma:: LNnDFH I;LEY-LACTOSE;LEWIS Y HEXASACCHARIDE;Lacto-N-neodifucohexaose 1;LACTO-N-NEO-DIFUCOHEXAOSE I;Lacto-N-neodifucohexaose I (LNnDFH I);α-fuc-(1→2)-β-gal-(1→4)(α-fuc-[1→3])-β-glcnac-(1→3)-β-gal-(1→4)-glc;ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC;Lacto-N-neo-difucohexaoseI, Ley-lactose, α-Fuc-(1-2)-β-Gal-(1-4)(α-Fuc-[1-3])-β-GlcNAc-(1-3)-β-Gal-(1-4)-Glc;D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 17

ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC Eigenschaften

Kennzeichnung gefährlicher	B
WGK Germany	3

cell differentiation marker, tumor related tetrasaccharide antigen

Global( 17)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
BOC Sciences	16314854226	inquiry@bocsci.com	United States	9713	58
Wuhan Tangzhi Pharmaceutical Co., Ltd.	027-63498076 13658392159	sale@glycogene.com	China	480	58
ShenZhen Trendseen Biological Technology Co.,Ltd.	13417589054 13417589054	trendseenbio@gmail.com	China	8941	58
Shanghai Saikerui Biotechnology Co. , Ltd.	021-58000709 15900491054	info@scrbio.com	China	9260	58
Shanghai Baosen Biotechnology Co., LTD	13482051552	sales_bcs@126.com	China	150	58
Shanghai Beiwanta Biotechnology Co., Ltd.	021-67187366 19901745723	info@bwtlab.com	China	9241	58
Hubei wei shi reagent group ltd., company	027-027-59102966 18717199209	2853877583@qq.com	China	5774	58
Carbosynth	--	sales@carbosynth.com	United Kingdom	6018	58

Lactose

LACTO-N-NEO-DIFUCOHEXAOSE I
LEWIS Y HEXASACCHARIDE
LEY-LACTOSE
α-fuc-(1→2)-β-gal-(1→4)(α-fuc-[1→3])-β-glcnac-(1→3)-β-gal-(1→4)-glc
ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC
Lacto-N-neo-difucohexaoseI, Ley-lactose, α-Fuc-(1-2)-β-Gal-(1-4)(α-Fuc-[1-3])-β-GlcNAc-(1-3)-β-Gal-(1-4)-Glc
Lacto-N-neodifucohexaose I (LNnDFH I)
LNnDFH I
O-6-Deoxy-alpha-L-galactopyranosyl-(1-2)-O-beta-D-galactopyranosyl-(1-4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1-3)]-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-3)-O-beta-D-galactopyranosyl-(1-4)-D-glucose
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]acetamide
D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
Lacto-N-neodifucohexaose 1
62469-99-2
C26H45NO19
Proteomics and Protein Expression
Carbohydrate Analysis
Carbohydrate Standards
BioChemical
Post-translational Modification
Proteomics